This Article is waiting for corrections.
ARTICLE
18 May 2024
Enveric Biosciences Sells Cannabinoid-Related IP To Focus On Emerging Psychedelic-Inspired Drugs
Enveric Biosciences ("Enveric") has reportedly now sold one of its portfolios comprised of patents and patent applications for cancer treatment that combines cannabidiol ("CBD")...